Company Filing History:
Years Active: 2024
Title: Inventor Nohan Nasser Abdelfattah Ahmed: Pioneering Anticancer Innovations
Introduction: Nohan Nasser Abdelfattah Ahmed is a notable inventor based in Riyadh, Saudi Arabia. With a strong commitment to advancing medical research, he has successfully filed one patent that showcases his innovative approach to treating cancer.
Latest Patents: Nohan's patent, titled "Synthesis and characterization of glauconite-based silicate nanorods as anticancer agent," presents a groundbreaking method of cytotoxically treating cancer using aluminum silicate nanorods (SNRs). These nanorods, which consist of aluminum, iron, magnesium, oxygen, potassium, and additional oxygen, are designed to be contacted with a cancerous sample at a concentration of 0.5 to 2 μg/mL. The SNRs have a longest dimension ranging from 100 nanometers (nm) to 5500 nm, with a diameter of 20 nm to 250 nm. With their porous structure, which features a pore size of 1 nm to 12 nm, the SNRs include cisplatin in amounts varying from 20 to 300 mg/g, demonstrating a significant reduction in cell viability upon contact with the cancerous sample.
Career Highlights: Nohan Nasser Abdelfattah Ahmed is affiliated with Imam Mohammad Ibn Saud Islamic University, where he contributes his expertise to various research initiatives aimed at enhancing cancer treatment methodologies. His dedication to innovation in the field of nanotechnology underpins his accomplishments and ongoing research endeavors.
Collaborations: Throughout his career, Nohan has collaborated with esteemed colleagues, including Hassan Ahmed Rudayni and Ahmed Aly Allam. These collaborations further emphasize his commitment to fostering innovative solutions in the medical field and advancing the understanding of nanotechnology applications in cancer treatment.
Conclusion: Nohan Nasser Abdelfattah Ahmed exemplifies the spirit of innovation in modern science, specifically within the realm of cancer research. His pioneering work on glauconite-based silicate nanorods reflects not only his individual scientific prowess but also the importance of collaboration within research institutions. As he continues to develop and refine his methodologies, his contributions are poised to make a significant impact in the fight against cancer.